25Jun
Blog: SEC Amendments to Financial Disclosure Requirements Provide a Welcome Reprieve for Carve-Out Transactions
As previously reported in this Cooley PubCo post, on May 21, the SEC adopted final amendments to the financial disclosure requirements for the acquisition and disposition of businesses. One change relating to the use of abbreviated financial statements stands out as a welcome reform for public or pre-public biopharma and life sciences companies....
By:
Cooley LLP
Related
In light of the COVID-19 pandemic, construction and design companies need to review their current co...
Read More >
We begin the second half of 2019 with the 1st of 2 parts on significant employment law trends and ca...
Read More >
“Anything you can do, I can do better.” That’s essentially the sentiment floating around Albany t...
Read More >
Yesterday, once again without an open meeting, the SEC voted (with a dissent from Commissioner Allis...
Read More >
On December 17, 2019, the US House of Representatives passed a year-end fiscal year 2020 spending bi...
Read More >
As we advised in June 2019, there was an unprecedented decision by Justice Melissa Crane of the New ...
Read More >